2005
DOI: 10.1016/j.jaad.2005.04.030
|View full text |Cite
|
Sign up to set email alerts
|

Corticosteroids: Options in the era of steroid-sparing therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
100
0
5

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 130 publications
(105 citation statements)
references
References 54 publications
0
100
0
5
Order By: Relevance
“…In the natural course of steroid atrophy, the first event is represented by a reduction in epidermal thickness [5], which is potentially reversible with early treatment readjustment [36]. Extended steroid use leads to additional dermal deterioration and striae formation which, unlike epidermal atrophy, tend to be persistent or irreversible [22].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In the natural course of steroid atrophy, the first event is represented by a reduction in epidermal thickness [5], which is potentially reversible with early treatment readjustment [36]. Extended steroid use leads to additional dermal deterioration and striae formation which, unlike epidermal atrophy, tend to be persistent or irreversible [22].…”
Section: Discussionmentioning
confidence: 99%
“…The first-line treatment for mild forms of disease consists of topical corticosteroids [3][4][5][6], with skin atrophy being the most severe potential side effect at the site of treatment [5,6]. The severity of the disease and the response to treatment are generally assessed using clinical scoring systems [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…They are very effective at mitigating inflammation; however, their side effects limit their long term use. Many of the new treatments are being sought as corticosteroids sparing alternatives (Del Rosso & Friedlander, 2005). Mechanism of Action: Corticosteroids bind intracellular receptors forming dimers that bind to the glucocorticoid response element of the promoter region of steroid responsive genes, which up regulates 10-100 genes (Bolognia et al, 2008).…”
Section: Corticosteroidsmentioning
confidence: 99%
“…Topical corticosteroids, such as betamethasone valerate (BMV), are the mainstay of treatment for steroid-responsive inflammatory dermatoses, including psoriasis, due to their anti-inflammatory, immunosuppressive, anti-proliferative and vasoconstrictive properties. In general, they inhibit dermal edema, capillary dilatation, movement of inflammatory cells within the skin and cellular proliferation in the dermis and epidermis (21,22).…”
mentioning
confidence: 99%